GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cogentix Medical Inc (NAS:CGNT) » Definitions » Net Cash per Share

Cogentix Medical (Cogentix Medical) Net Cash per Share : $0.27 (As of Dec. 2017)


View and export this data going back to 1992. Start your Free Trial

What is Cogentix Medical Net Cash per Share?

Net Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities minus Total Liabilities minus Minority Interest and then divided by Shares Outstanding (EOP). Cogentix Medical's Net Cash per Share for the quarter that ended in Dec. 2017 was $0.27.

The historical rank and industry rank for Cogentix Medical's Net Cash per Share or its related term are showing as below:

CGNT's Price-to-Net-Cash is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 7.16
* Ranked among companies with meaningful Price-to-Net-Cash only.

Cogentix Medical Net Cash per Share Historical Data

The historical data trend for Cogentix Medical's Net Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cogentix Medical Net Cash per Share Chart

Cogentix Medical Annual Data
Trend Mar08 Mar09 Mar10 Mar11 Mar12 Mar13 Mar14 Mar15 Dec16 Dec17
Net Cash per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.08 -2.54 -0.96 0.21 0.27

Cogentix Medical Quarterly Data
Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17
Net Cash per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.21 0.22 0.27 0.26 0.27

Competitive Comparison of Cogentix Medical's Net Cash per Share

For the Medical Devices subindustry, Cogentix Medical's Price-to-Net-Cash, along with its competitors' market caps and Price-to-Net-Cash data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cogentix Medical's Price-to-Net-Cash Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Cogentix Medical's Price-to-Net-Cash distribution charts can be found below:

* The bar in red indicates where Cogentix Medical's Price-to-Net-Cash falls into.



Cogentix Medical Net Cash per Share Calculation

In the calculation of a company's Net Cash per Share, assets other than cash and short term investments are considered to be worth nothing. But the company has to pay its debt and other liabilities in full. This is an extremely conservative way of valuation. Most companies have negative Net Cash per Share. But sometimes a company's price may be lower than its net-cash.

Cogentix Medical's Net Cash per Share for the fiscal year that ended in Dec. 2017 is calculated as

Net Cash per Share (A: Dec. 2017 )
=(Cash, Cash Equivalents, Marketable Securities-Total Liabilities-Minority Interest)/Shares Outstanding (EOP)
=(27.157-10.708-0)/60.9057
=0.27

Cogentix Medical's Net Cash per Share for the quarter that ended in Dec. 2017 is calculated as

Net Cash per Share (Q: Dec. 2017 )
=(Cash, Cash Equivalents, Marketable Securities-Total Liabilities-Minority Interest)/Shares Outstanding (EOP)
=(27.157-10.708-0)/60.9057
=0.27

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cogentix Medical  (NAS:CGNT) Net Cash per Share Explanation

Ben Graham invested in situations where the company's stock price was lower than its net-cash. He assigned some value to the company's other current asset. The value is called Net Current Asset Value (NCAV). One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.

You can find companies that are traded below their Net Current Asset Value (NCAV) with our Net-Net screener.


Cogentix Medical Net Cash per Share Related Terms

Thank you for viewing the detailed overview of Cogentix Medical's Net Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Cogentix Medical (Cogentix Medical) Business Description

Traded in Other Exchanges
N/A
Address
5420 Feltl Road, Minnetonka, MN, USA, 55343
Cogentix Medical Inc is a medical device company. The company designs, develops, manufactures and markets a robust line of high-performance fiberoptic and video endoscopy products under the PrimeSight brand that is used across multiple surgical specialties in diagnostic and treatment procedures. Cogentix offers the Urgent PC Neuromodulation System, a device that delivers percutaneous tibial nerve stimulation (PTNS), for the office-based treatment of overactive bladder (OAB). It also develops Macroplastique an injectable, urethral bulking agent for the treatment of adult female stress urinary incontinence primarily resulting from intrinsic sphincter deficiency.
Executives
Nachum Shamir director 12212 TECHNOLOGY BLVD, AUSTIN TX 78727
Brett Reynolds officer: SVP, CFO, Treasurer 5000 W 36TH STREET, MINNEAPOLIS MN 55416
Kenneth A Samet director 800 KING FARM BOULEVARD, 4TH FLOOR, ROCKVILLE MD 20850
Uri Geiger director 221 LATHROP WAY, SUITE I, SACRAMENTO CA 95815
Accelmed Growth Partners, L.p. 10 percent owner 6 HACHOSHLIM STREET, 6TH FLOOR, HERZLIYA PITUACH L3 4672406
Accelmed Growth Partners Management Ltd. 10 percent owner 6 HACHOCHLIM STREET, 6TH FLOOR, HERZLIYA PITUACH L3 4672406
Accelmed Growth Partners (gp), L.p. 10 percent owner 6 HACHOCHLIM STREET, 6TH FLOOR, HERZLIYA PITUACH L3 4672406
Accelmed Growth Partners (agp) Ltd 10 percent owner 6 HACHOCHLIM STREET, 6TH FLOOR, HERZLIYA PITUACH L3 4672406
Cheryl Pegus director 40 RAMLAND ROAD, ORANGEBURG CA 10962
Kenneth H Paulus director 5420 FELTL ROAD, MINNETONKA MN 55343
Sven Wehrwein director
Kevin H Roche director
David W Anderson director 519 LYNMERE ROAD, BRYN MAWR PA 19010

Cogentix Medical (Cogentix Medical) Headlines

From GuruFocus

Cognyte Announces Appointment of Avi Cohen to Board of Directors

By Business Wire Business Wire 05-09-2023